Home › Employers › Oricell Therapeutics Inc.
Oricell Therapeutics Inc.: H-1B salaries and sponsorship
Oricell Therapeutics Inc. filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 2. Median offered salary: $198,000.
Does Oricell Therapeutics Inc. sponsor H-1B visas?
Oricell Therapeutics Inc. filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on May 10, 2024. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| Senior Clinical Operation Director | 1 | — |
| Senior Clinical Operations Director | 1 | $216,000 |
| Associate Director of MSAT | 1 | $180,000 |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2023 | 2 | $216,000 |
| FY2024 | 1 | $180,000 |
Prevailing wage levels
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Where the jobs are
Occupations
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| Associate Director of MSAT | $180,000 Level II | Roseland, NJ | May 10, 2024 | May 20, 2024 | Certified |
| Senior Clinical Operations Director | $216,000 E-3 · Level III | Irvine, CA | Mar 30, 2023 | Apr 24, 2023 | Certified |
| Senior Clinical Operation Director | $216,000 E-3 · Level III | Irvine, CA | Mar 29, 2023 | Apr 24, 2023 | Withdrawn |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).